F-group (family)
5069.1.3.4 CybS
Ligands and drugs
103
Member domains
67
with ligand contacts (≤ 4 Å)
65.0% of members
65
with DrugDomain annotations
63.1% of members
65
with a DrugBank compound
63.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5069.1.3.4 belongs to X-group 5069 Transmembrane heme-binding four-helical bundle, which binds 7.6 ligand superclasses per 20 proteins, narrower than 50% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB18267 | HEM | Ferroheme | 64 |
| DB03047 | EPH | L-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine | 34 |
| DB04327 | PEE | Phosphatidylethanolamine | 5 |
| DB04631 | AT5 | Atpenin A5 | 5 |
| DB04657 | CBE | Carboxin | 4 |
| DB08689 | UQ1 | Ubiquinone Q1 | 4 |
| DB04795 | TTF | Thenoyltrifluoroacetone | 2 |
| DB00730 | TMG | Thiabendazole | 1 |
| DB00756 | — | Hexachlorophene | 1 |
| DB04141 | — | 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol | 1 |
| DB19376 | SLI | Salicylanilide | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 65 |
| EPH | L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE | 34 |
| UNL | Unknown ligand | 14 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 7 |
| FTN | N-[3-(1-methylethoxy)phenyl]-2-(trifluoromethyl)benzamide | 7 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 7 |
| AT5 | 3-[(2S,4S,5R)-5,6-DICHLORO-2,4-DIMETHYL-1-OXOHEXYL]-4-HYDROXY-5,6-DIMETHOXY-2(1H)-PYRIDINONE | 5 |
| UQ1 | UBIQUINONE-1 | 5 |
| CBE | 2-METHYL-N-PHENYL-5,6-DIHYDRO-1,4-OXATHIINE-3-CARBOXAMIDE | 4 |
| 12J | 2-iodo-N-[3-(1-methylethoxy)phenyl]benzamide | 3 |
| E23 | N-(4-tert-butylbenzyl)-2-(trifluoromethyl)benzamide | 3 |
| F6A | N-biphenyl-3-yl-2-(trifluoromethyl)benzamide | 3 |
| FD8 | N-[3-(pentafluorophenoxy)phenyl]-2-(trifluoromethyl)benzamide | 3 |
| MRN | 2-methyl-N-[3-(1-methylethoxy)phenyl]benzamide | 3 |
| 4YP | 2-amino-5-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-3-methoxy-6-methylcyclohexa-2,5-diene-1,4-dione | 2 |
| E24 | N-(2,4-dichlorobenzyl)-2-(trifluoromethyl)benzamide | 2 |
| PEV | (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | 2 |
| RQX | 2-amino-3-methoxy-6-methyl-5-[(2E)-3-methylhex-2-en-1-yl]cyclohexa-2,5-diene-1,4-dione | 2 |
| TTF | 4,4,4-TRIFLUORO-1-THIEN-2-YLBUTANE-1,3-DIONE | 2 |
| UQ | Coenzyme Q10, (2Z,6E,10Z,14E,18E,22E,26Z)-isomer | 2 |